Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2012 Nov 8:11:370.
doi: 10.1186/1475-2875-11-370.

The Affordable Medicines Facility-malaria--a success in peril

Ambrose O Talisuna  1 , Seraphine Adibaku, Chioma N Amojah, George K Amofah, Vivian Aubyn, Alex Dodoo, Elizabeth Juma, Djermakoye H Jackou, Sigsbert Mkude, Albert P Okui, Benjamin Ramarosandratana, Shija J Shija
Affiliations
Editorial

The Affordable Medicines Facility-malaria--a success in peril

Ambrose O Talisuna et al. Malar J. .

Abstract

The Affordable Medicines Facility-malaria (AMFm) has put into place a bold financing plan for artemisinin-combination therapy in a pilot phase in seven countries covering half the population at risk of malaria in Africa. A report of the AMFm independent evaluation, conducted by ICF International and the London School of Hygiene and Tropical Medicine, describes the success of the programme in the pilot sites: Ghana, Kenya, Madagascar, Niger, Nigeria, Tanzania (mainland and Zanzibar) and Uganda, comparing availability and affordability of high-quality artemisinin-combination therapies before and after AMFm launched. Proof of concept was achieved: AMFm increased availability and kept prices low, meeting its initial, ambitious benchmarks in most settings. Despite this overwhelming success, opposition to the programme and dwindling resources for malaria control conspire to cripple or kill AMFm.

PubMed Disclaimer

References

    1. Arrow K, Panosian C, Gelband H. Saving Lives, Buying Time: Economics of Malaria Drugs in an Age of Resistance. Washington, DC: The National Academies Press; 2004. - PubMed
    1. Yamey G, Schaferhoff M, Montagu D. Piloting the affordable medicines facility-malaria: what will success look like? Bull World Health Organ. 2012;90:452–460. - PMC - PubMed
    1. Final Report of the Independent Evaluation of AMFm Phase 1. http://www.theglobalfund.org/en/amfm/independentevaluation/
    1. Tougher S, Ye Y, Amuasi JH, Kourgueni IA, Thomson R, Goodman C, Mann AG, Ren R, Willey BA, Adegoke CA, Amin A, Ansong D, Bruxvoort K, Diallo DA, Diap G, Festo C, Johanes B, Juma E, Kalolella A, Malam O, Mberu B, Ndiaye S, Nguah SB, Seydou M, Taylor M, Rueda ST, Wamukoya M, Arnold F, Hanson K, the ACTwatch Group. Eff ect of the Aff ordable Medicines Facility—malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: a before-and-after analysis of outlet survey data. Lancet. 2012. http://dx.doi.org/10.1016/S0140-6736(12)61732-2. - DOI - PubMed
    1. Trape F. The public health impact of chloroquine resistance in Africa. Am J Trop Med Hyg. 2001;64(1–2 Suppl):12–7. - PubMed

Publication types

MeSH terms